References
- Cao, J. L., Li, X. L., Li, C. X., Xue, C. M., Chen, S. H., Gao, S., Gao, Y., Guan, S. J., Guo, G. M., He, T., Hua, G, D., Huang, M. Z., Kong, X. W., … Zou, A. Y. (2022). Expert consensus on clinical application of Chinese patent medicine (First Edition). Chinese Pharmaceutical Journal, 57(6), 502–506. doi:10.11669/cpj.2022.06.012
- Center for Drug Evaluation National Medical Products Administration. (2023). Domestic drug technology guidelines. Retrieved July 31, 2023, from https://www.cde.org.cn/zdyz/listpage/9cd8db3b7530c6fa0c86485e563f93c7. (Chinese).
- Chan, E., Tan, M., Xin, J., Sudarsanam, S., & Johnson, D. E. (2010). Interactions between traditional Chinese medicines and Western therapeutics. Current Opinion in Drug Discovery & Development, 13(1), 50–65.
- Chinese Medicine Council of Hong Kong. (2023). Lists of applications for proprietary Chinese medicine registration. Retrieved July 31, 2023, from https://www.cmchk.org.hk/pcm/eng/#main_listpcm_2023.htm (English).
- Chinese Medicine Council of Hong Kong. (2023). Registration of proprietary Chinese medicines. Retrieved July 31, 2023, from https://www.cmchk.org.hk/pcm/eng/#main_down02.htm. (English).
- Department of Social Culture. (2021). Directive No. 88/2021 of the Secretary for Social Affairs and Culture. Retrieved April 30, 2023, from https://bo.io.gov.mo/bo/i/2021/52/despsasc_cn.asp#95.
- Directive No. 95/2021 of the Secretary for Social Affairs and Culture. (2021). List of Chinese medicinal materials used in the Macao special administrative region. Retrieved April 30, 2023, from https://bo.io.gov.mo/bo/i/2021/52/despsasc_cn.asp#95
- General Administration of Customs of the People’s Republic of China. (2023). Customs statistics. Retrieved July 31, 2023, from http://stats.customs.gov.cn/. (Chinese).
- Governor of Macau. (1990). Establishes and regulates the registration of pharmaceuticals used in Macau (Decree No. 59/90/M). Retrieved July 31, 2023, from https://bo.io.gov.mo/bo/i/90/38/declei59_cn.asp. (Chinese).
- Governor of Macau. (1995). Establishes the legal system for pharmaceutical advertising (Decree No. 30/95/M). Retrieved July 31, 2023, from https://bo.io.gov.mo/bo/i/95/28/declei30_cn.asp (Chinese).
- Guangdong Provincial Drug Administration. (2021). Guangdong Provincial drug administration on simplifying the registration approval of traditional external chinese MEDICINES Already on the Market in Hong Kong and Macao. Retrieved April 30, 2023, from http://mpa.gd.gov.cn/xwdt/tzgg/content/post_3498158.html (Chinese).
- Guangdong Provincial Drug Administration. (2022). Detailed rules for the registration and record-filing of medical institution preparations in Guangdong Province. Retrieved July 31, 2023, from http://www.gd.gov.cn/zwgk/gongbao/2022/34/content/post_4066564.html (Chinese).
- Hong Kong Department of Justice. (2023). Hong Kong e-Legislation. Retrieved July 31, 2023, from https://www.elegislation.gov.hk/hk/cap549!en?INDEX_CS=N (English).
- Legislative Assembly of Macau. (1989). Establishes a series of rules regulating advertising activities (Law No. 7/89/M). Retrieved July 31, 2023, from https://bo.io.gov.mo/bo/i/89/36/lei07_cn.asp (Chinese).
- Legislative Assembly of Macau. (1990). Regulates the activities of the pharmaceutical profession and the pharmaceutical industry (Decree No. 58/90/M). Retrieved July 31, 2023, from https://bo.io.gov.mo/bo/i/90/38/declei58_cn.asp (Chinese).
- Legislative Assembly of Macau. (2003). Foreign trade law (Law No. 7/2003). Retrieved July 31, 2023, from https://www.isaf.gov.mo/wp-content/uploads/2022/12/lei-7-2003.pdf (Chinese).
- Legislative Assembly of Macau. (2022). Regulatory system for hazardous goods (Law No. 12/2022). Retrieved July 31, 2023, from https://bo.io.gov.mo/bo/i/2022/34/lei12_cn.asp (Chinese).
- Legislative Council of Hong Kong. 2012 Trade Descriptions Ordinance (Cap. 362). Retrieved April 30, 2023, from https://www.elegislation.gov.hk/hk/cap362!zh-Hant-HK
- Legislative Council of Hong Kong. (2012). Undesirable medical advertisements ordinance (Cap. 231). Retrieved April 30, 2023, from https://www.elegislation.gov.hk/hk/cap231!zh-Hant-HK.
- Legislative Council of Hong Kong. (2015). Pharmacy and Poisons Ordinance (Cap. 138). Retrieved April 30, 2023, from https://www.elegislation.gov.hk/hk/cap138!zh-Hant-HK (Chinese).
- Legislative Council of Hong Kong. (2018). Chinese Medicine Ordinance (Cap. 549). Retrieved April 30, 2023, from https://www.elegislation.gov.hk/hk/cap549!zh-Hant-HK (Chinese).
- Legislative Council of Hong Kong. (2019). Public health and municipal services ordinance (Cap. 132). Retrieved April 30, 2023, from https://www.elegislation.gov.hk/hk/cap132!zh-Hant-HK.
- Legislative Council of Hong Kong. (2020). Consumer Goods Safety Ordinance (Cap. 456). Retrieved April 30, 2023, from https://www.elegislation.gov.hk/hk/cap456
- Legislative Council of Hong Kong. (2021). Protection of endangered species of animals and plants ordinance (Cap. 586). Retrieved April 30, 2023, from https://www.elegislation.gov.hk/hk/cap586!zh-Hant-HK
- Legislative Council of Hong Kong. (2021). Import and Export Ordinance (Cap. 60). Retrieved April 30, 2023, from https://www.elegislation.gov.hk/hk/cap60!zh-Hant-HK
- Li, J., Zhu, J., Hu, H., Harnett, J. E., Lei, C. I., Chau, K. Y., … Ung, C. O. L. (2018). Internationalization of Traditional/Complementary Medicine products: market entry as medicine. Chinese Medicine, 13(1), 50. doi:10.1186/s13020-018-0209-6
- Lin, A. X., Chan, G., Hu, Y., Ouyang, D., Ung, C. O. L., Shi, L., … Hu, H. (2018). Internationalization of traditional Chinese medicine: current international market, internationalization challenges and prospective suggestions. Chinese Medicine, 13(1), 9. doi:10.1186/s13020-018-0167-z
- Luo, L., Jiang, J., Wang, C., Fitzgerald, M., Hu, W., Zhou, Y. … Zhang, H. (2020). Analysis on herbal medicines utilized for treatment of COVID-19. Acta Pharmaceutica Sinica B, 10(7), 1192–1204. doi:10.1016/j.apsb.2020.05.007
- Macao Daily News. (2023). Tourism + health and wellness: Macau's development direction. Retrieved August 14, 2023, from http://www.macaodaily.com/html/2023-08/12/content_1694005.htm (Chinese).
- Macau Government Printing Bureau. (2023). Legislation. https://www.io.gov.mo/cn/legis. (Chinese).
- Macau Pharmaceutical Administration Bureau. (2021). TCM pharmaceutical activities and proprietary Chinese medicines Registration Law (Law No.11/2021). Retrieved July 31, 2023, from https://bo.io.gov.mo/bo/i/2021/30/lei11_cn.asp (Chinese).
- Macau Pharmaceutical Administration Bureau. (2022). Rules for naming traditional Chinese medicine, as well as technical requirements for packaging, labeling, and instructions (Directive No. 25/ISAF/2022). Retrieved April 30, 2023, from https://bo.io.gov.mo/bo/ii/2022/13/avisosoficiais_cn.asp#isaf6
- Macau Pharmaceutical Administration Bureau. (2023). Statistics data. Retrieved July 31, 2023, from https://www.isaf.gov.mo/%e6%9c%80%e6%96%b0%e8%b3%87%e8%a8%8a/%e7%b5%b1%e8%a8%88%e6%95%b8%e6%93%9a.
- Macau Pharmaceutical Administration Bureau. (2023). Laws and regulations. Retrieved July 31, 2023, from https://www.isaf.gov.mo/%e6%b3%95%e5%be%8b%e6%b3%95%e8%a6%8f/. (Chinese).
- National Medical Products Administration. (2019). NMPA organizations. Retrieved July 31, 2023, from http://english.nmpa.gov.cn/2019-07/19/c_389169.htm (Chinese).
- National Medical Products Administration. (2020). Classification of traditional Chinese medicine registration and requirements for application materials. Retrieved April 40, 2023, from https://www.nmpa.gov.cn/directory/web/nmpa/xxgk/ggtg/qtggtg/20200928164311143.html (Chinese).
- National Medical Products Administration. (2021). Interim provisions on the management of imported Hong Kong and Macao drugs and medical devices urgently needed in clinical practice in the mainland of the Guangdong-Hong Kong-Macao Greater Bay Area. Retrieved April 30, 2023, from http://mpa.gd.gov.cn/zwgk/gzwj/content/post_3498412.html (Chinese).
- National Medical Products Administration. (2022). Technical guidelines for revision of safety information in instructions for marketed Chinese medicine (Trial) (No. 1 of 2022). Retrieved April 30, 2023, from https://www.nmpa.gov.cn/yaopin/ypggtg/20220107145808154.html. (Chinese).
- National Medical Products Administration. (2023a). Regulatory document. Retrieved July 31, 2023, from https://www.nmpa.gov.cn/xxgk/fgwj/index.html (Chinese).
- National Medical Products Administration. (2023b). The special provisions for traditional Chinese medicines registration. Retrieved April 30, 2023, from https://www.nmpa.gov.cn/xxgk/fgwj/xzhgfxwj/20230210173401120.html. (Chinese).
- National Medical Products Administration; National Health Commission of the People’s Republic of China. (2020). Pharmacopoeia of the People's Republic of China. Retrieved April 30, 2023, from http://www.gov.cn/xinwen/2020-11/28/content_5565608.htm. (Chinese).
- National People's Congress. (2018). The traditional Chinese medicine law of the People's Republic of China. Retrieved July 31, 2023, from http://www.nhc.gov.cn/fzs/s3576/201808/a6b71efcea4546bf89241252d0659eb6.shtml (Chinese).
- Office of The Ombudsman Hong Kong. (2018). Government’s regulation of proprietary Chinese medicine. Retrieved July 31, 2023 (Chinese).
- People's Congress of Guangdong Province. (2021). Guangdong provincial traditional Chinese medicine regulations. Retrieved July 31, 2023, from http://szyyj.gd.gov.cn/zwyw/bmwj/content/post_3556311.html (Chinese).
- Security National Medical Insurance Administration & Ministry of Human Resources and Social. (2023). National basic medical insurance, work injury insurance, and maternity insurance drug list (2022). Retrieved July 31, 2023, from https://www.gov.cn/zhengce/zhengceku/2023-01/18/content_5737840.htm (Chinese).
- Standing Committee of the Thirteenth National People's Congress. (2019). Pharmaceutical administration law of the People's Republic of China. Retrieved July 31, 2023. (Chinese).
- State Council of China. (1988). Regulations for the management of toxic drugs for medical use. Retrieved April 30, 2023, from http://www.nhc.gov.cn/fzs/s3576/201808/a9ae9e1fbab04a9e8c4a8ca91c037975.shtml (Chinese).
- State Council of China. (2019). The outline development plan for the Guangdong-Hong Kong-Macau Greater Bay Area. Retrieved July 31, 2023, from https://www.gov.cn/zhengce/2019-02/18/content_5366593.htm#1 (Chinese).
- The Basic Law of The Hong Kong Special Administrative Region of The People’s Republic of China. (2021). Chapter VI, Article 138. Retrieved April 40, 2023, from https://www.basiclaw.gov.hk/en/basiclaw/chapter6.html.
- The National Administration of Traditional Chinese Medicine. (2020). The construction plan for a high ground of traditional Chinese medicine in the Guangdong-Hong Kong-Macau Greater Bay Area (2020-2025). Retrieved July 31, 2023, from https://www.gov.cn/xinwen/2020-10/22/content_5553451.htm (Chinese).
- World Health Organization. (2018). Traditional and complementary medicine in primary health care. Retrieved April 40, 2023, from https://apps.who.int/iris/handle/10665/326299.
- World Health Organization. (2019). WHO global report on traditional and complementary medicine. Retrieved April 40, 2023, from https://apps.who.int/iris/handle/10665/312342.
- Xu, J., & Yang, Y. (2009). Traditional Chinese medicine in the Chinese health care system. Health Policy, 90(2-3), 133–139. doi:10.1016/j.healthpol.2008.09.003